PRDSPARDES BIOSCIENCES, INC.

Nasdaq pardesbio.com


$ 2.15 $ 0.00 (0 %)    

Wednesday, 30-Aug-2023 15:41:14 EDT
QQQ $ 431.01 $ 6.55 (1.54 %)
DIA $ 382.27 $ 1.39 (0.36 %)
SPY $ 508.26 $ 4.77 (0.95 %)
TLT $ 88.26 $ 0.46 (0.52 %)
GLD $ 216.60 $ 0.70 (0.32 %)
$ 2.16
$ 2.14
$ 2.13 x 1,100
$ 2.61 x 100
$ 2.14 - $ 2.15
$ 0.75 - $ 3.67
2,378,978
na
125.56M
$ 0.19
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-04-2023 06-30-2023 10-Q
2 05-05-2023 03-31-2023 10-Q
3 03-14-2023 12-31-2022 10-K
4 11-07-2022 09-30-2022 10-Q
5 08-15-2022 06-30-2022 10-Q
6 05-10-2022 03-31-2022 10-Q
7 03-29-2022 12-31-2021 10-K
8 11-12-2021 09-30-2021 10-Q
9 08-16-2021 06-30-2021 10-Q
10 05-17-2021 03-31-2021 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 medipacific-offering-213-per-share-plus-one-contingent-value-right-per-share-in-tender-offer-for-pardes-biosciences

- Reuters

 medipacific-reports-calculation-of-additional-price-per-share-and-extension-of-expiration-date-for-tender-offer-for-pardes-biosciences-shares

The total cash amount that Purchaser will pay pursuant to the terms of the Offer and the Merger Agreement is $2.13 per share.

 jmp-securities-downgrades-pardes-biosciences-to-market-perform

JMP Securities analyst Roy Buchanan downgrades Pardes Biosciences (NASDAQ:PRDS) from Market Outperform to Market Perform.

 why-acumen-pharmaceuticals-shares-are-trading-higher-by-over-60-here-are-other-stocks-moving-in-mondays-mid-day-session

Gainers ProMIS Neurosciences, Inc. (NASDAQ: PMN) shares jumped 126.6% to $6.37. ProMIS showcased preclinical data at the Al...

 why-pardes-biosciences-shares-are-rising-monday

Pardes Biosciences Inc (NASDAQ: PRDS) shares are trading higher Monday after MediPacific agreed to acquire the company. 

 pardes-biosciences-q1-eps-030-beats-041-estimate

Pardes Biosciences (NASDAQ:PRDS) reported quarterly losses of $(0.30) per share which beat the analyst consensus estimate of $(...

 svb-leerink-downgrades-pardes-biosciences-to-market-perform-lowers-price-target-to-2

SVB Leerink analyst Roanna Ruiz downgrades Pardes Biosciences (NASDAQ:PRDS) from Outperform to Market Perform and lowers the...

 why-american-public-education-shares-are-trading-lower-by-around-49-here-are-other-stocks-moving-in-wednesdays-mid-day-session

Gainers ThermoGenesis Holdings, Inc. (NASDAQ: THMO) shares jumped 80% to $3.7820 after the company announced the roll out o...

 jmp-securities-maintains-market-outperform-on-pardes-biosciences-lowers-price-target-to-5

JMP Securities analyst Roy Buchanan maintains Pardes Biosciences (NASDAQ:PRDS) with a Market Outperform and lowers the price...

 pardes-biosciences-q4-eps-041-beats-050-estimate

Pardes Biosciences (NASDAQ:PRDS) reported quarterly losses of $(0.41) per share which beat the analyst consensus estimate of $(...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION